3rd Disclosure and Transparency for Clinical Data Summit – 3rd Disclosure and Transparency for Clinical Data Summit

The life science and clinical data transparency industry must take a collaborative approach to achieve data disclosure compliance to combat the burden of new regulatory requirements and renewed infrastructure needs. Within these new regulatory changes, both the U.S and global level develop strategies to release patient-level data and anonymous data to achieve meaningful patient engagement.

At ExL’s 3rd Disclosure and Transparency for Clinical Data Summit attendees will gain comprehensive, high-quality education that balances commercial values and ethical responsibility through the execution of national and global data transparency.

Top Five Reasons to Attend

  1. Understand the impact of GDPR on sharing and clinical trial data
  2. Gain insight on utilizing clinical data and view data sharing
  3. Discuss best practices for managing global disclosure
  4. Differentiate legal perspectives and legal procedures for data sharing
  5. Improve communications to achieve patient involvement

Who Should Attend

This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:

  • Clinical Trial Disclosure and Transparency
  • Clinical Trial Information Disclosure/Management
  • Clinical Operations
  • Data Management/Standards
  • Regulatory Affairs
  • Clinical Trial Registration
  • Publication Planning
  • Medical Writing
  • Information/Knowledge Management
  • Strategic Projects Management
  • Medical Communications
  • Patient Engagement
  • Biostatistics/Bioinformatics

This event is also of interest to:

  • Data Reporting/Transparency Solution Providers
  • Medical Writing/Publication Services
  • Discrepancy Management/Data Management Service Providers
  • Legal Consultants
End Date

Address : 3rd Disclosure and Transparency for Clinical Data Summit